I think these results are pleasantly good imo. Most analyst were predicting a much larger drop off in revenue for this FY as most assumed covid was going to be eradicated once the vaccines were released.
Either way, through a longer term lens, the number of trained clinicians who have now heard of and used airvo 2 and optiflow systems have increased enormously around the world.
Ann: Fisher & Paykel Healthcare provides FY22 trading update, page-3
Add FPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.06 |
Change
-0.240(0.91%) |
Mkt cap ! $15.21B | |||
| Open | High | Low | Value | Volume |
| $26.28 | $26.36 | $25.95 | $5.757M | 220.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 171 | $25.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.06 | 3808 | 2 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$26.05 |
Change
-0.240 ( 0.74 %) |
||||
| Open | High | Low | Volume | ||
| $26.24 | $26.35 | $25.96 | 277590 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| FPH (ASX) Chart |